171 related articles for article (PubMed ID: 36845294)
41. Evaluation of 1p and 14q status, MIB-1 labeling index and progesterone receptor immunoexpression in meningiomas: Adjuncts to histopathological grading and predictors of aggressive behavior.
Kumar S; Kakkar A; Suri V; Kumar A; Bhagat U; Sharma MC; Singh M; Suri A; Sarkar C
Neurol India; 2014; 62(4):376-82. PubMed ID: 25237942
[TBL] [Abstract][Full Text] [Related]
42. Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases.
Palma L; Celli P; Franco C; Cervoni L; Cantore G
J Neurosurg; 1997 May; 86(5):793-800. PubMed ID: 9126894
[TBL] [Abstract][Full Text] [Related]
43. Skull base atypical meningioma: long term surgical outcome and prognostic factors.
Wang YC; Chuang CC; Wei KC; Hsu YH; Hsu PW; Lee ST; Wu CT; Tseng CK; Wang CC; Chen YL; Jung SM; Chen PY
Clin Neurol Neurosurg; 2015 Jan; 128():112-6. PubMed ID: 25486076
[TBL] [Abstract][Full Text] [Related]
44. DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management.
Nassiri F; Mamatjan Y; Suppiah S; Badhiwala JH; Mansouri S; Karimi S; Saarela O; Poisson L; Gepfner-Tuma I; Schittenhelm J; Ng HK; Noushmehr H; Harter P; Baumgarten P; Weller M; Preusser M; Herold-Mende C; Tatagiba M; Tabatabai G; Sahm F; von Deimling A; ; Zadeh G; Aldape KD
Neuro Oncol; 2019 Jul; 21(7):901-910. PubMed ID: 31158293
[TBL] [Abstract][Full Text] [Related]
45. Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.
Zhu H; Bi WL; Aizer A; Hua L; Tian M; Den J; Tang H; Chen H; Wang Y; Mao Y; Dunn IF; Xie Q; Gong Y
Cancer Med; 2019 Jan; 8(1):13-20. PubMed ID: 30680963
[TBL] [Abstract][Full Text] [Related]
46. Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection.
Sun SQ; Kim AH; Cai C; Murphy RK; DeWees T; Sylvester P; Dacey RG; Grubb RL; Rich KM; Zipfel GJ; Dowling JL; Leuthardt EC; Leonard JR; Evans J; Simpson JR; Robinson CG; Perrin RJ; Huang J; Chicoine MR
Neurosurgery; 2014 Oct; 75(4):347-54; discussion 354-5; quiz 355. PubMed ID: 24932707
[TBL] [Abstract][Full Text] [Related]
47. Atypical meningiomas: is postoperative radiotherapy indicated?
Lee KD; DePowell JJ; Air EL; Dwivedi AK; Kendler A; McPherson CM
Neurosurg Focus; 2013 Dec; 35(6):E15. PubMed ID: 24289123
[TBL] [Abstract][Full Text] [Related]
48. Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution.
Hua L; Zhu H; Li J; Tang H; Kuang D; Wang Y; Tang F; Chen X; Zhou L; Xie Q; Gong Y
J Neurosurg; 2018 Jun; 128(6):1698-1706. PubMed ID: 28820306
[TBL] [Abstract][Full Text] [Related]
49. Specific gene expression signatures of low grade meningiomas.
Tsitsikov EN; Hameed S; Tavakol SA; Stephens TM; Tsytsykova AV; Garman L; Bi WL; Dunn IF
Front Oncol; 2023; 13():1126550. PubMed ID: 36937440
[TBL] [Abstract][Full Text] [Related]
50. World Health Organization Grade II Meningiomas: The Role of Adjuvant/Salvage Gamma Knife Surgery After Initial Surgery and Prognostic Factor Assessment.
Liu X; Shan B; Wang M; Xu J
World Neurosurg; 2018 Jan; 109():e352-e362. PubMed ID: 28987849
[TBL] [Abstract][Full Text] [Related]
51. Characteristics of midline suprasellar meningiomas based on their origin and growth pattern.
Liu Y; Chotai S; Ming C; Jin S; Pan J; Qi S
Clin Neurol Neurosurg; 2014 Oct; 125():173-81. PubMed ID: 25171391
[TBL] [Abstract][Full Text] [Related]
52. Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
Góes P; Santos BFO; Suzuki FS; Salles D; Stávale JN; Cavalheiro S; de Paiva Neto MA
J Neurooncol; 2018 Apr; 137(2):331-336. PubMed ID: 29270884
[TBL] [Abstract][Full Text] [Related]
53. Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications.
Cai DX; Banerjee R; Scheithauer BW; Lohse CM; Kleinschmidt-Demasters BK; Perry A
J Neuropathol Exp Neurol; 2001 Jun; 60(6):628-36. PubMed ID: 11398839
[TBL] [Abstract][Full Text] [Related]
54. Is DNA Methylation a Ray of Sunshine in Predicting Meningioma Prognosis?
Shen L; Lin D; Cheng L; Tu S; Wu H; Xu W; Pan Y; Wang X; Zhang J; Shao A
Front Oncol; 2020; 10():1323. PubMed ID: 33014773
[TBL] [Abstract][Full Text] [Related]
55. Molecular Profiling of 22 Primary Atypical Meningiomas Shows the Prognostic Significance of 18q Heterozygous Loss and
Barresi V; Simbolo M; Fioravanzo A; Piredda ML; Caffo M; Ghimenton C; Pinna G; Longhi M; Nicolato A; Scarpa A
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33670055
[TBL] [Abstract][Full Text] [Related]
56. Significance of the Extent of Resection in Modern Neurosurgical Practice of World Health Organization Grade I Meningiomas.
Winther TL; Torp SH
World Neurosurg; 2017 Mar; 99():104-110. PubMed ID: 27867123
[TBL] [Abstract][Full Text] [Related]
57. Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases.
Palma L; Celli P; Franco C; Cervoni L; Cantore G
Neurosurg Focus; 1997 Apr; 2(4):e3. PubMed ID: 15096007
[TBL] [Abstract][Full Text] [Related]
58. Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic.
Williams EA; Santagata S; Wakimoto H; Shankar GM; Barker FG; Sharaf R; Reddy A; Spear P; Alexander BM; Ross JS; Brastianos PK; Cahill DP; Ramkissoon SH; Juratli TA
Acta Neuropathol Commun; 2020 Oct; 8(1):171. PubMed ID: 33087175
[TBL] [Abstract][Full Text] [Related]
59. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
[TBL] [Abstract][Full Text] [Related]
60. Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.
Raleigh D; Chen W; Choudhury A; Youngblood M; Polley MY; Lucas CH; Mirchia K; Maas S; Suwala A; Won M; Bayley J; Harmanci A; Harmanci A; Klisch T; Nguyen M; Vasudevan H; McCortney K; Yu T; Bhave V; Lam TC; Pu J; Leung G; Chang J; Perlow H; Palmer J; Haberler C; Berghoff A; Preusser M; Nicolaides T; Mawrin C; Agnihotri S; Resnick A; Rood B; Chew J; Young J; Boreta L; Braunstein S; Schulte J; Butowski N; Santagata S; Spetzler D; Bush NAO; Villanueva-Meyer J; Chandler J; Solomon D; Rogers C; Pugh S; Mehta M; Sneed P; Berger M; Horbinski C; McDermott M; Perry A; Bi W; Patel A; Sahm F; Magill S
Res Sq; 2023 Mar; ():. PubMed ID: 36993741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
